Covered recipient · General Payments record
ZACHARY GIBSON
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,096.58
- Reported across 116 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $309.81 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $136.54 | 8 |
| Novo Nordisk AS | $46.03 | 3 |
| Amgen Inc. | $44.98 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.51 | 1 |
| Grifols USA, LLC | $23.20 | 1 |
| Lilly USA, LLC | $17.29 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $16.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.22 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107169299 | CMS |
| ABBVIE INC. | $16.96 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107169301 | CMS |
| ABBVIE INC. | $1.64 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107169303 | CMS |
| ABBVIE INC. | $23.21 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107169305 | CMS |
| ABBVIE INC. | $13.48 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107169307 | CMS |
| ABBVIE INC. | $23.13 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107169309 | CMS |
| ABBVIE INC. | $17.12 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107169311 | CMS |
| ABBVIE INC. | $22.78 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107169313 | CMS |
| Amgen Inc. | $13.24 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117562224 | CMS |
| Amgen Inc. | $15.68 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117562226 | CMS |
| Amgen Inc. | $16.06 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117562228 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.51 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118082568 | CMS |
| Boston Scientific Corporation | $16.26 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092664629 | CMS |
| Grifols USA, LLC | $23.20 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124717474 | CMS |
| Lilly USA, LLC | $17.29 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135994042 | CMS |
| Novo Nordisk Inc | $15.18 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100656257 | CMS |
| Novo Nordisk Inc | $15.97 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100349220 | CMS |
| Novo Nordisk Inc | $14.88 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100428501 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.